In this article, we will look at the 5 Stocks With Unexpected Gains. For a deeper discussion and an extended list, please see 10 Stocks With Unexpected Gains.

5. Almonty Industries Inc. (NASDAQ:ALM)

Almonty rallied for a fourth straight session on Monday, jumping 8.27 percent to close at $16.63 apiece, as investors loaded portfolios ahead of the official start of its tungsten mine operations in South Korea.

In a statement last week, Almonty Industries Inc. (NASDAQ:ALM) said that it has already completed the redevelopment of the Sangdong mine site and is now ready to start mining operations.

It can be learned that Almonty Industries Inc. (NASDAQ:ALM) acquired the tungsten mine when the US halted its mining operations in 2015. Since then, it has worked on bringing the site back into production.

Phase 1 of the facility is designed to process approximately 640,000 tons of ore annually, while a phase 2 expansion, scheduled for 2027, is expected to further bolster production capacity.

The Sangdong mine is seen to be one of the largest and longest-life tungsten sites outside of China, capable of supplying approximately 40 percent of global demand, positioning the listed firm as a cornerstone supplier to Western markets.

Earlier, Almonty Industries Inc. (NASDAQ:ALM) Chairman, President, and CEO Lewis Black said that the company has already secured binding hard floor offtake agreements, including long-term commitments, to supply tungsten oxide for US defense applications.

This, he said, provided future revenue visibility and validated the strategic value of the company’s production.

4. Venture Global Inc. (NYSE:VG)

Venture Global saw its share prices jump by 8.88 percent on Monday to close at $15.94 apiece, as investors resorted to bargain-hunting following four straight days of decline, while mirroring the broader market optimism.

On the same day, Wall Street’s three main indices all finished in the green, with the Nasdaq leading gains by 0.54 percent, followed by the S&P 500, up 0.44 percent, and the Dow Jones, jumping 0.36 percent.

In other news, Venture Global Inc. (NYSE:VG) late last month announced that it finally settled an arbitration case filed by Edison SpA in relation to its failure to supply the latter with liquefied natural gas (LNG) from its Calcasieu Pass facility in Louisiana within the committed time.

The two companies inked a long-term LNG supply contract in 2017, with deliveries supposed to begin around 2022 to 2023.

Venture Global Inc. (NYSE:VG) said that completion of the settlement is expected this quarter, with LNG deliveries targeted for next month.

“The agreement represents a significant step in strengthening commercial cooperation between the parties and it establishes a foundation for further future deliveries in the context of the disruption caused by ongoing geopolitical events,” Venture Global Inc. (NYSE:VG) said.

“Both parties welcome this agreement, as it further consolidates long‑term deliveries and enhances the commercial partnership between Venture Global and Edison, which is an important foundational customer of the Calcasieu Pass project. The parties look forward to continuing to work together to pursue Venture Global’s mission of stabilizing global LNG/gas markets and to further consolidate Edison’s role in guaranteeing the stability and security of Italy’s energy supply,” it noted.

3. Amprius Technologies Inc. (NYSE:AMPX)

Amprius Technologies saw its share prices increase by 9.75 percent to close at $17.56 apiece, as investors took heart from the booming demand for electric vehicles, which sparked buying appetite for its stock.

According to reports, EVs are getting a boost from the ongoing tensions in the Middle East, as customers try to mitigate risks from the surging crude oil prices.

A report by online vehicles marketplace Autotrader last month said that it saw a 28 percent jump in inquiries for new EVs, while 15 percent have inquired about used ones, since the US-Israeli war on Iran started on February 28.

Optimism for EVs, on the other hand, spilled over to battery stocks, including Amprius Technologies Inc. (NYSE:AMPX), backed by earlier reports that it secured $21 million worth of orders for its SiCore cylindrical cells from a premier EV maker in China.

The batteries will be installed in its range of light electric vehicles, including scooters, three-wheelers, and motorcycles.

Citing a study by Ratel Consulting, Amprius Technologies Inc. (NYSE:AMPX) said that the battery market for light electric vehicles such as e-scooters, e-bikes, three-wheelers, and electric motorcycles, among others, is growing at a 15 percent compound annual growth rate and is projected to reach 26 GWh by 2030.

2. Plug Power Inc. (NASDAQ:PLUG)

Plug Power saw its share prices jump by 11.62 percent on Monday to close at $2.69 apiece, as investors loaded portfolios ahead of expected business updates next week.

This after the company said that its newly installed Chief Executive Officer (CEO), Jose Luis Crespo, will host a live Reddit Ask Me Anything (AMA) session on Thursday, April 16, 2026, at 10 AM to 12 NN ET.

The session would provide participants the opportunity to engage directly with Crespo and hear about Plug Power Inc.’s (NASDAQ:PLUG) strategic direction, market position, execution priorities and role in advancing the global hydrogen economy.

Last month, Crespo officially assumed the CEO role from being president and chief revenue officer (CRO) for the company. As CRO, Crespo helped drive growth through cost discipline, margin expansion, and capital efficiency, resulting in revenues hitting more than $700 million last year from only $27 million in 2013.

He also deepened strategic partnerships with global customers, including Amazon, Walmart, Home Depot, Gal,p and Iberdrola, while advancing hydrogen fuel cell and electrolyzer deployments across multiple industries.

Crespo replaced Andy Marsh, who transitioned to chairman of Plug Power Inc.’s (NASDAQ:PLUG) board of directors, consistent with the leadership transition plan announced last October.

1. Soleno Therapeutics Inc. (NASDAQ:SLNO)

Soleno Therapeutics soared by 32.31 percent on Monday to close at $52.25 apiece, as investors gobbled up shares following news that it is set to be acquired by Neurocrine Biosciences Inc. at a 34-percent upside.

In a statement, Neurocrine said that it entered into a definitive agreement with Soleno Therapeutics Inc. (NASDAQ:SLNO) for the acquisition of all its issued and outstanding shares at a price of $53 apiece, for a total of $2.9 billion.

Prior to the announcement, Soleno Therapeutics Inc. (NASDAQ:SLNO) last traded at $39.49.

The merger is set to expand Neurocrine’s portfolio of innovative medicines, with the addition of VYKAT XR, and strengthen its leadership position in endocrinology and rare disease.

Since securing the approval of the Food and Drug Administration last year, VYKAT XR has already generated $190 million in 2025 revenues for Soleno Therapeutics Inc. (NASDAQ:SLNO), of which $92 million was registered in the fourth quarter alone.

“Neurocrine is the right strategic partner to expand the reach of VYKAT XR in the Prader-Willi syndrome community, given their experience in endocrinology and rare disease and their proven ability to execute successful commercial launches. We are excited to accelerate VYKAT XR’s impact for PWS patients following completion of the transaction by leveraging Neurocrine’s strong commercial capabilities,” said Soleno Therapeutics Inc. (NASDAQ:SLNO) Chairman and Chief Executive Officer Anish Bhatnagar.

READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge fund investor letters by entering your email below.